BUY Akums Drugs and Pharmaceuticals — Citigroup
byCitigroupHorizon: NA (inferred 1 year)18 Aug 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·21 Oct · yesterday
1 other SEBI-registered advisor has an active long-term BUY call on this stock
Advisor consensus · same horizon·11 Aug · 2mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Akums Drugs and Pharmaceuticals
- BUY — Anand James, Geojit Investments22 Sept 2026 · ~2 weeks · target ₹860 · SL hit
- BUY — Ashish Kyal, Waves Strategy Advisors15 Sept 2026 · ~2 weeks · target ₹830 · SL hit
- BUY — Sumeet Bagadia, Choice Broking15 Sept 2026 · ~2 weeks · target ₹865 · Expired
- BUY — Kush Bohra19 Aug 2026 · ~2 weeks · target ₹795 · Target hit
- BUY — Citigroup18 Aug 2026 · ~1 year · target ₹840 · Active
More from Citigroup
- BUY Eternal22 Oct 2026 · ~1 year · target ₹420 · Active
- BUY Eternal22 Oct 2026 · ~1 year · target ₹390 · Active
- BUY Mahindra & Mahindra Financial Services22 Oct 2026 · ~1 year · target ₹420 · Active
- SELL L&T Technology Services21 Oct 2026 · ~1 year · target ₹3,115 · Active
- BUY Reliance Industrial Infrastructure21 Oct 2026 · ~1 year · target ₹1,020 · Active

